Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Calificación de consenso1
Outperform
Precio objetivo más alto1
$20.00
Precio objetivo más bajo1
$2.00
Precio objetivo consensuado1
$12.88
Replimune Group Inc tiene un precio objetivo de consenso de $12.88 basado en las calificaciones de 10 analistas. El máximo es $20, emitido por JP Morgan el agosto 7, 2026. El mínimo es $2, emitido por Jefferies el abril 13, 2026. Las 3 calificaciones de analistas más recientes fueron publicadas por JP Morgan, Wedbush y Leerink Partners el agosto 7, 2026, agosto 7, 2026 y agosto 4, 2026, respectivamente. Con un precio objetivo promedio de $18.67 entre JP Morgan, Wedbush y Leerink Partners, hay una 33.33% upside implícita para Replimune Group Inc según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
El último precio objetivo de Replimune Group (NASDAQ:REPL) fue comunicado por JP Morgan el agosto 7, 2026. La firma de analistas fijó un precio objetivo para $20.00 que espera REPL a rise dentro de 12 meses (un posible 42.86% upside). 22 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Replimune Group (NASDAQ:REPL) fue proporcionada por JP Morgan, y Replimune Group mantuvo su overweight calificación.
La última revisión al alza de Replimune Group Inc se produjo en agosto 7, 2026, cuando Wedbush elevó su precio objetivo a $19. Wedbush anteriormente tenía a neutral para Replimune Group Inc.
La última revisión a la baja de Replimune Group Inc se produjo en abril 13, 2026, cuando Cantor Fitzgerald cambió su precio objetivo de N/A a N/A para Replimune Group Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Replimune Group, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Replimune Group se registró el agosto 7, 2026, por lo que la próxima calificación estará disponible en torno al agosto 7, 2027.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Replimune Group (REPL) fue un mantuvo con un precio objetivo de $17.00 a $20.00. El precio actual al que cotiza Replimune Group (REPL) es de $14.00, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.
Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas
Datos de mercado proporcionados por APIs de Benzinga
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 08/07/2026 | Buy Now | 42.86% | JP Morgan | $17 → $20 | Maintains | Overweight | Get Alert |
| 08/07/2026 | Buy Now | 35.71% | Wedbush | $12 → $19 | Upgrade | Neutral → Outperform | Get Alert |
| 08/04/2026 | Buy Now | 21.43% | Leerink Partners | $11 → $17 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/31/2026 | Buy Now | — | Cantor Fitzgerald | — | Upgrade | Neutral → Overweight | Get Alert |
| 07/31/2026 | Buy Now | -14.29% | Wedbush | $9 → $12 | Maintains | Neutral | Get Alert |
| 06/30/2026 | Buy Now | -35.71% | Wedbush | $6 → $9 | Maintains | Neutral | Get Alert |
| 06/01/2026 | Buy Now | -57.14% | Wedbush | $2 → $6 | Maintains | Neutral | Get Alert |
| 04/13/2026 | Buy Now | — | Cantor Fitzgerald | — | Downgrade | Overweight → Neutral | Get Alert |
| 04/13/2026 | Buy Now | -85.71% | Leerink Partners | $11 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 04/13/2026 | Buy Now | — | JP Morgan | — | Downgrade | Neutral → Underweight | Get Alert |
| 04/13/2026 | Buy Now | -85.71% | Wedbush | $19 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 04/13/2026 | Buy Now | -85.71% | Jefferies | $13 → $2 | Downgrade | Buy → Hold | Get Alert |
| 04/13/2026 | Buy Now | — | HC Wainwright & Co. | — | Downgrade | Buy → Sell | Get Alert |
| 02/05/2026 | Buy Now | — | Piper Sandler | $13 → $14 | Maintains | Overweight | Get Alert |
| 02/04/2026 | Buy Now | 35.71% | Wedbush | $18 → $19 | Maintains | Outperform | Get Alert |
| 11/03/2025 | Buy Now | -21.43% | BMO Capital | $2 → $11 | Upgrade | Underperform → Market Perform | Get Alert |
| 10/27/2025 | Buy Now | -14.29% | HC Wainwright & Co. | → $12 | Upgrade | Neutral → Buy | Get Alert |
| 10/20/2025 | Buy Now | -21.43% | JP Morgan | → $11 | Upgrade | Underweight → Neutral | Get Alert |
| 10/20/2025 | Buy Now | -7.14% | Leerink Partners | $3 → $13 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/20/2025 | Buy Now | 28.57% | Wedbush | $4 → $18 | Upgrade | Neutral → Outperform | Get Alert |
| 09/19/2025 | Buy Now | — | JP Morgan | — | Downgrade | Neutral → Underweight | Get Alert |
| 09/08/2025 | Buy Now | — | HC Wainwright & Co. | — | Reiterates | Neutral → Neutral | Get Alert |
| 07/30/2025 | Buy Now | — | Cantor Fitzgerald | — | Upgrade | Neutral → Overweight | Get Alert |
| 07/23/2025 | Buy Now | -85.71% | BMO Capital | $27 → $2 | Downgrade | Outperform → Underperform | Get Alert |
| 07/23/2025 | Buy Now | -78.57% | Barclays | $17 → $3 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/23/2025 | Buy Now | — | HC Wainwright & Co. | — | Downgrade | Buy → Neutral | Get Alert |
| 07/22/2025 | Buy Now | -78.57% | Leerink Partners | $21 → $3 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/22/2025 | Buy Now | -35.71% | JP Morgan | $19 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 07/22/2025 | Buy Now | -57.14% | Jefferies | $31 → $6 | Maintains | Buy | Get Alert |
| 07/22/2025 | Buy Now | -71.43% | Wedbush | $19 → $4 | Downgrade | Outperform → Neutral | Get Alert |
| 07/16/2025 | Buy Now | 35.71% | JP Morgan | $16 → $19 | Maintains | Overweight | Get Alert |
| 07/03/2025 | Buy Now | 57.14% | HC Wainwright & Co. | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2025 | Buy Now | — | Cantor Fitzgerald | — | Initiates | → Overweight | Get Alert |
| 06/02/2025 | Buy Now | 57.14% | Piper Sandler | $14 → $22 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | 28.57% | JP Morgan | $16 → $18 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 57.14% | HC Wainwright & Co. | $21 → $22 | Maintains | Buy | Get Alert |
| 01/22/2025 | Buy Now | 92.86% | BMO Capital | $18 → $27 | Maintains | Outperform | Get Alert |
| 01/22/2025 | Buy Now | 50% | HC Wainwright & Co. | $17 → $21 | Maintains | Buy | Get Alert |
| 12/04/2024 | Buy Now | 35.71% | Jefferies | $16 → $19 | Maintains | Buy | Get Alert |
| 11/22/2024 | Buy Now | 28.57% | BMO Capital | $14 → $18 | Maintains | Outperform | Get Alert |
| 11/22/2024 | Buy Now | 21.43% | HC Wainwright & Co. | $17 → $17 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 21.43% | HC Wainwright & Co. | $17 → $17 | Reiterates | Buy → Buy | Get Alert |
| 09/24/2024 | Buy Now | 21.43% | JP Morgan | $14 → $17 | Maintains | Overweight | Get Alert |
| 09/16/2024 | Buy Now | 21.43% | HC Wainwright & Co. | $17 → $17 | Reiterates | Buy → Buy | Get Alert |
| 09/10/2024 | Buy Now | 21.43% | HC Wainwright & Co. | $17 → $17 | Reiterates | Buy → Buy | Get Alert |
| 08/27/2024 | Buy Now | 21.43% | Roth MKM | → $17 | Initiates | → Buy | Get Alert |
| 08/13/2024 | Buy Now | — | JP Morgan | $17 → $14 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 21.43% | Barclays | $13 → $17 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 21.43% | HC Wainwright & Co. | $12 → $17 | Maintains | Buy | Get Alert |
| 12/06/2023 | Buy Now | -7.14% | Barclays | $50 → $13 | Maintains | Overweight | Get Alert |
| 11/13/2023 | Buy Now | 242.86% | HC Wainwright & Co. | $50 → $48 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 271.43% | Wedbush | → $52 | Reiterates | Outperform → Outperform | Get Alert |